HEALTHY CHOICE WELLNESS CORP (HCWC) Stock Fundamental Analysis
USA - NYSEARCA:HCWC - US42227T1051 - Common Stock
0.5698 USD
-0.03 (-4.83%)
0.575 USD
+0.01 (+0.91%)
Overall HCWC gets a fundamental rating of 3 out of 10. We evaluated HCWC against 39 industry peers in the Consumer Staples Distribution & Retail industry. HCWC has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, HCWC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year HCWC has reported negative net income.
In the past year HCWC had a positive cash flow from operations.
1.2 Ratios
HCWC has a Return On Assets of -11.71%. This is amonst the worse of the industry: HCWC underperforms 82.05% of its industry peers.
The Return On Equity of HCWC (-73.95%) is worse than 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.71% | ||
| ROE | -73.95% | ||
| ROIC | N/A |
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HCWC has a better Gross Margin (39.65%) than 87.18% of its industry peers.
In the last couple of years the Gross Margin of HCWC has grown nicely.
HCWC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HCWC has about the same amount of shares outstanding.
Compared to 1 year ago, HCWC has a worse debt to assets ratio.
2.2 Solvency
HCWC has an Altman-Z score of 2.17. This is not the best score and indicates that HCWC is in the grey zone with still only limited risk for bankruptcy at the moment.
HCWC has a worse Altman-Z score (2.17) than 71.79% of its industry peers.
The Debt to FCF ratio of HCWC is 5.54, which is a neutral value as it means it would take HCWC, 5.54 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.54, HCWC perfoms like the industry average, outperforming 56.41% of the companies in the same industry.
HCWC has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of HCWC (1.51) is worse than 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 5.54 | ||
| Altman-Z | 2.17 |
ROIC/WACCN/A
WACC9.25%
2.3 Liquidity
HCWC has a Current Ratio of 1.10. This is a normal value and indicates that HCWC is financially healthy and should not expect problems in meeting its short term obligations.
HCWC's Current ratio of 1.10 is in line compared to the rest of the industry. HCWC outperforms 46.15% of its industry peers.
HCWC has a Quick Ratio of 1.10. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
HCWC has a Quick ratio (0.58) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
HCWC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.68%, which is quite impressive.
HCWC shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.57%.
HCWC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 83.46% yearly.
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.11%
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%29.53%
3.2 Future
Based on estimates for the next years, HCWC will show a very strong growth in Earnings Per Share. The EPS will grow by 24.21% on average per year.
HCWC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.78% yearly.
EPS Next Y37.14%
EPS Next 2Y24.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
HCWC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HCWC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
HCWC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HCWC is more expensive than 74.36% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HCWC is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.48 | ||
| EV/EBITDA | 36.08 |
4.3 Compensation for Growth
HCWC's earnings are expected to grow with 24.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.21%
EPS Next 3YN/A
5. Dividend
5.1 Amount
HCWC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.5698
-0.03 (-4.83%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners1.19%
Inst Owner Change0%
Ins Owners14.76%
Ins Owner Change0%
Market Cap7.86M
Revenue(TTM)78.34M
Net Income(TTM)-4.26M
Analysts82.86
Price Target2.04 (258.02%)
Short Float %1.39%
Short Ratio0.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.98%
Min EPS beat(2)31.37%
Max EPS beat(2)70.59%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.19%
Min Revenue beat(2)4.54%
Max Revenue beat(2)5.83%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.1 | ||
| P/FCF | 4.48 | ||
| P/OCF | 3.75 | ||
| P/B | 1.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 36.08 |
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.13
FCFY22.33%
OCF(TTM)0.15
OCFY26.66%
SpS5.68
BVpS0.42
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.71% | ||
| ROE | -73.95% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.65% | ||
| FCFM | 2.24% |
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
F-Score6
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 5.54 | ||
| Debt/EBITDA | 23.56 | ||
| Cap/Depr | 19.85% | ||
| Cap/Sales | 0.43% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 569.03% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.17 |
F-Score6
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)22.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.11%
EPS Next Y37.14%
EPS Next 2Y24.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%29.53%
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.36%
OCF growth 3YN/A
OCF growth 5YN/A
HEALTHY CHOICE WELLNESS CORP / HCWC FAQ
What is the fundamental rating for HCWC stock?
ChartMill assigns a fundamental rating of 3 / 10 to HCWC.
What is the valuation status of HEALTHY CHOICE WELLNESS CORP (HCWC) stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHY CHOICE WELLNESS CORP (HCWC). This can be considered as Overvalued.
How profitable is HEALTHY CHOICE WELLNESS CORP (HCWC) stock?
HEALTHY CHOICE WELLNESS CORP (HCWC) has a profitability rating of 2 / 10.
How financially healthy is HEALTHY CHOICE WELLNESS CORP?
The financial health rating of HEALTHY CHOICE WELLNESS CORP (HCWC) is 2 / 10.